Crossmark Global Holdings’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$212K Sell
3,287
-66
-2% -$4.65K ﹤0.01% 1178
2025
Q4
$226K Buy
+3,353
New +$226K ﹤0.01% 1145
2023
Q1
Sell
-18,928
Closed -$1.08M 1303
2022
Q4
$1.08M Sell
18,928
-4,194
-18% -$215K 0.03% 548
2022
Q3
$914K Sell
23,122
-654
-3% -$28.9K 0.03% 569
2022
Q2
$1.05M Sell
23,776
-2,750
-10% -$119K 0.03% 553
2022
Q1
$1.06M Buy
26,526
+4,450
+20% +$159K 0.02% 599
2021
Q4
$888K Buy
22,076
+1,760
+9% +$65.7K 0.02% 666
2021
Q3
$826K Buy
20,316
+46
+0.2% +$1.92K 0.02% 675
2021
Q2
$920K Sell
20,270
-30
-0.1% -$1.33K 0.02% 644
2021
Q1
$846K Buy
20,300
+330
+2% +$15.1K 0.02% 653
2020
Q4
$853K Buy
+19,970
New +$718K 0.02% 614

Other funds holding HALO